Yunnan Botanee Bio-Technology Group Co (300957.SZ) Stock Price
Yunnan Botanee Bio-Technology Group Co Price
Over the last 8 years Yunnan Botanee Bio-Technology Group Co grew revenue by 26.9% annually, reaching 5.36 B CNY. Earnings per share have grown at 16.1% per year over the last 8 years. For Yunnan Botanee Bio-Technology Group Co, the net margin of 9.4% is down versus 21.5% a few years ago. At today's price the dividend yield works out to roughly 2.04%. The payout ratio is around 50% of earnings. The dividend has grown at 7.5% per year over the past 4 years. The consensus 12-month price target for Yunnan Botanee Bio-Technology Group Co is 44.63 CNY, about 51.4% above where the stock trades today. Of 16 analysts, 10 rate the stock a buy — an overall Buy consensus.
Yunnan Botanee Bio-Technology Group Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Yunnan Botanee Bio-Technology Group Co business model & stock analysis
Frequently asked questions about Yunnan Botanee Bio-Technology Group Co
Analysts currently set an average price target of 44.75 CNY for the Yunnan Botanee Bio-Technology Group Co stock (median: 44.63 CNY), implying +51.2 % versus the latest price. The consensus is based on 16 analyst ratings.
Yunnan Botanee Bio-Technology Group Co Analyst Price Targets 2026
17 analysts currently rate the Yunnan Botanee Bio-Technology Group Co stock: 10 recommend buying, 6 holding and 1 selling. For 2026, analysts expect Yunnan Botanee Bio-Technology Group Co to generate revenue of 5.85 B CNY and earnings per share of 1.42 CNY.
Yunnan Botanee Bio-Technology Group Co Analyst Price Targets 2026
Converted at the current exchange rate, the Yunnan Botanee Bio-Technology Group Co share trades at 3.95 EUR (29.48 CNY).
The Yunnan Botanee Bio-Technology Group Co share (300957.SZ) is listed on 1 stock exchanges, including: Shenzhen (300957.SZ).
The expected revenue of Yunnan Botanee Bio-Technology Group Co is 5.85 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Yunnan Botanee Bio-Technology Group Co is 597.28 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Yunnan Botanee Bio-Technology Group Co is currently 20.73. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Yunnan Botanee Bio-Technology Group Co stock.
The price-to-sales ratio (P/S) of Yunnan Botanee Bio-Technology Group Co is currently 2.12. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Yunnan Botanee Bio-Technology Group Co stock.
The Eulerpool Quality Score for Yunnan Botanee Bio-Technology Group Co is 3/10.
The ISIN of Yunnan Botanee Bio-Technology Group Co is CNE100004G74. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Yunnan Botanee Bio-Technology Group Co is 300957.SZ. The ticker symbol is used to trade Yunnan Botanee Bio-Technology Group Co shares on the stock exchange.
Yunnan Botanee Bio-Technology Group Co stock
Yunnan Botanee Bio-Technology Group Co Peer Group
Yunnan Botanee Bio-Technology Group Co Ticker
Yunnan Botanee Bio-Technology Group Co FIGI
All fundamentals and in-depth analysis of Yunnan Botanee Bio-Technology Group Co
Our stock analysis for Yunnan Botanee Bio-Technology Group Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yunnan Botanee Bio-Technology Group Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.